RT @NatureMedicine: ROR-γ is key in castration-resistant #prostatecancer & is a potential therapeutic target for the disease: https://t.co/…
ROR-γ is key in castration-resistant #prostatecancer & is a potential therapeutic target for the disease: https://t.co/XgJaGoIy7g #AACR16
ROR-gamma drives androgen receptor expression and represents a therapeutic target in CR prostate cancer https://t.co/6UpImZdnhw
A therapeutic target in castration-resistant #prostate #cancer https://t.co/Lt7BspodEh
#EZH2 amplification in castration resistant #prostate #cancer https://t.co/bwB80POw2B https://t.co/ptovGgY6f1
ROR-γ drives androgen receptor expression and is a therapeutic target in castration-resistant prostate cancer https://t.co/bm4mfPcpC6
ROR-γ drives androgen receptor expression and represents a therapeutic target in cast... https://t.co/Bvx2aoopXs | https://t.co/m4OIzTIdU9
RT @NatureMedicine: .@UCD_Cancer study shows ROR-γ is a novel therapeutic target for metastatic castration-resistant #prostatecancer: https…
RT @NatureMedicine: .@UCD_Cancer study shows ROR-γ is a novel therapeutic target for metastatic castration-resistant #prostatecancer: https…
RT @NatureMedicine: .@UCD_Cancer study shows ROR-γ is a novel therapeutic target for metastatic castration-resistant #prostatecancer: https…
RT @NatureMedicine: .@UCD_Cancer study shows ROR-γ is a novel therapeutic target for metastatic castration-resistant #prostatecancer: https…
.@UCD_Cancer study shows ROR-γ is a novel therapeutic target for metastatic castration-resistant #prostatecancer: https://t.co/1iE5JpR5Fr
ROR-[gamma] drives androgen receptor expression & represents therapeutic target in castration-resist prostate cancer https://t.co/LE1owiaYvd